Recombinant Activated Factor VII as a Second Line Treatment for Postpartum Hemorrhage.

Soon Chang Park Seok-Ran YeomSang Kyoon HanYoung Mo JoHyung Bin Kim

Published in: Korean journal of critical care medicine (2017)

This analysis aimed to support that the administration of rFVIIa can reduce the severity of life-threatening PPH in patients. A rapid decision regarding the administration of rFVIIa is needed for a more favorable outcome in severe PPH patients for whom there is no effective standard treatment.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
patient reported outcomes
combination therapy
patient reported
data analysis